000 01454 a2200457 4500
005 20250514042904.0
264 0 _c20021028
008 200210s 0 0 eng d
022 _a1462-0324
024 7 _a10.1093/rheumatology/41.9.1025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFont, J
245 0 0 _aThe role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
_h[electronic resource]
260 _bRheumatology (Oxford, England)
_cSep 2002
300 _a1025-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDNA
_xanalysis
650 0 4 _aFemale
650 0 4 _aGene Frequency
650 0 4 _aHaplotypes
650 0 4 _aHeterozygote
650 0 4 _aHumans
650 0 4 _aInterleukin-10
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPolymorphism, Genetic
650 0 4 _aSjogren's Syndrome
_xgenetics
700 1 _aGarcía-Carrasco, M
700 1 _aRamos-Casals, M
700 1 _aAldea, A I
700 1 _aCervera, R
700 1 _aIngelmo, M
700 1 _aVives, J
700 1 _aYagüe, J
773 0 _tRheumatology (Oxford, England)
_gvol. 41
_gno. 9
_gp. 1025-30
856 4 0 _uhttps://doi.org/10.1093/rheumatology/41.9.1025
_zAvailable from publisher's website
999 _c12089945
_d12089945